0 items
Your cart is empty.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
$598.00
This product is available by prescription only
This product does not require a prescription
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
The 50mg vial provides maximum peptide availability for GLP-1 receptor investigations. This format reduces vial frequency, streamlines supply management, and supports coordinated workflows across large research teams. The lyophilized presentation enables extended stability under controlled laboratory storage conditions.
Semaglutide is a GLP-1 receptor agonist widely examined in incretin signaling, metabolic pathway modeling, and receptor interaction research. Its extended receptor engagement profile supports time-course assays, comparative pathway analysis, and structured pharmacodynamic modeling in controlled in-vitro environments.
All Semaglutide 50mg batches are produced in certified U.S. pharmaceutical facilities operating under strict GMP systems. Each order includes a Certificate of Analysis detailing purity verification, molecular identity testing, and batch-specific quality metrics. The product is designed exclusively for analytical evaluation and laboratory research.
Semaglutide 50mg is intended for professional research entities conducting structured GLP-1 receptor pathway investigations and large-scale analytical programs.
This concentration is appropriate for:
Manufactured in USA GMP-certified facilities, Semaglutide 50mg includes batch-level purity verification, molecular identity confirmation, and submission-grade documentation to support rigorous institutional research standards.
For Research Use Only.
The 50mg concentration offers operational advantages for organizations managing extensive multi-arm investigations. Consolidated procurement and reduced handling requirements improve logistical efficiency across multi-site research networks. Long-duration programs benefit from consistent peptide availability with minimized supply interruptions.
Semaglutide 50mg supports structured analysis of GLP-1 receptor signaling, glucose pathway modeling, lipid interaction studies, inflammatory marker research, cardiovascular pathway evaluation, and metabolic adaptation mechanisms within controlled in-vitro systems.
Independent analytical testing confirms approximately 99% purity. This level of validation supports reproducible receptor interaction studies and standardized laboratory outcomes across extended development timelines.
The high-concentration format simplifies coordination across distributed research facilities. Teams conducting comparative receptor pathway analyses or large-scale dataset generation can maintain standardized material consistency throughout multi-phase programs.
Working concentrations and dilution models are determined exclusively by institutional research design. Laboratories establish experimental frameworks in accordance with internal validation standards and regulatory documentation requirements.
Store lyophilized Semaglutide at 2–8°C in monitored laboratory refrigeration. After reconstitution using validated laboratory-grade solvents, maintain controlled temperature conditions and adhere to sterile preparation protocols. Proper handling preserves peptide integrity and analytical reliability.
Cold-chain shipping is not required; however, refrigerated storage under monitored laboratory conditions is necessary upon receipt. Protection from light exposure supports long-term stability.
Long-duration investigative programs examining GLP-1 receptor dynamics, pharmacokinetic modeling, biomarker interaction patterns, and pathway response mechanisms may utilize the 50mg concentration to maintain uninterrupted research continuity across multi-year timelines.
Each batch undergoes full analytical verification with approximately 99% purity confirmation through validated testing procedures. This supports consistent laboratory reproducibility and regulatory-aligned documentation requirements.
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
High-purity, research-grade peptide synthesis
Analytical testing to verify quality and composition
Consistent batch-to-batch performance
Batch identification on every vial for traceability
Stored and shipped under controlled conditions
A synthetic GHRH analog studied for receptor binding kinetics, molecular interaction modeling, and pulsatile signaling pathway investigation in preclinical settings.
Research-grade synthetic dual-agonist peptide formulated in higher-quantity 15mg format for extended dual-receptor pathway studies and institutional peptide research in controlled laboratory environments.
Research-grade synthetic thymic peptide formulated in 10mg quantity for immune peptide studies and thymosin mechanism research in controlled laboratory environments.
GHK-Cu (50mg): High-purity copper-coordinated tripeptide complex provided in 50mg format for laboratory research involving metal-binding chemistry and extracellular signaling pathway analysis.
Research-grade synthetic dual-peptide formulation combining amylin analog and GLP-1 receptor agonist for dual-mechanism pathway studies and combination peptide research in controlled laboratory environments.
